Literature DB >> 30465188

Managing Refractory Postoperative Fistulas as Chronic Wounds Using Video-Assisted Hydrodebridement (VAHD).

Marguerite Changala1, Jeanne Laberge2, Robert Kerlan2, Andrew Taylor2, Mustafa Arain3, Kimberly Kirkwood4.   

Abstract

Postoperative fistula formation remains a serious complication following abdominal surgical procedures. Refractory fistulas requiring further surgical intervention delay adjuvant chemotherapy and functional recovery. Here, we present six cases of refractory fistulas and describe a new management technique, which we call video-assisted hydrodebridement. We postulate that refractory fistulas are a type of chronic wound, for which hydrodebridement may be used to hasten wound healing. In all cases, patients had undergone a prolonged period of conservative management and surgical intervention was not considered appropriate. Here, we describe the steps of the procedure in detail. We achieved timely closure of the refractory fistula in five of six cases. The median duration of attempted conservative management was 122 days (63-346 days) and median time to fistula closure after the procedure was 35 days (22-64 days) in the five successful cases. The findings during each procedure are discussed. We suspect that this procedure applies the same benefits to refractory fistulas that hydrodebridement provides to chronic wounds. The combination of endoscopic exploration and hydrodebridement can elucidate barriers to fistula resolution while creating a clean base for wound healing. This technique may be a useful tool to reduce the morbidity of refractory fistula management.

Entities:  

Keywords:  Chronic wound; Hydrodebridement; Postoperative fistula

Mesh:

Year:  2018        PMID: 30465188     DOI: 10.1007/s11605-018-4046-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  9 in total

Review 1.  Wound bed preparation: a systematic approach to wound management.

Authors:  Gregory S Schultz; R Gary Sibbald; Vincent Falanga; Elizabeth A Ayello; Caroline Dowsett; Keith Harding; Marco Romanelli; Michael C Stacey; Luc Teot; Wolfgang Vanscheidt
Journal:  Wound Repair Regen       Date:  2003-03       Impact factor: 3.617

Review 2.  Debridement for Surgical Wounds.

Authors:  Christine Moreno Smith
Journal:  Crit Care Nurse       Date:  2015-08       Impact factor: 1.708

3.  The efficiency of burn wounds debridement with use of hydrosurgery--our experiences.

Authors:  Marek Kawecki; Karolina Mikuś-Zagórska; Justyna Glik; Mariusz Nowak
Journal:  Pol Przegl Chir       Date:  2015-03-01

4.  Pulsed lavage: promoting comfort and healing in home care.

Authors:  D Morgan; J Hoelscher
Journal:  Ostomy Wound Manage       Date:  2000-04       Impact factor: 2.629

5.  [Our experience with hydro-debridement in varied skin lesions. Technical and innovating advance in pediatric surgery].

Authors:  C Hernández Castelló; R Beltrà Picó; F González López
Journal:  Cir Pediatr       Date:  2009-10

6.  Factors influencing the treatment of intra-abdominal abscesses.

Authors:  M A Malangoni; C R Shumate; H A Thomas; J D Richardson
Journal:  Am J Surg       Date:  1990-01       Impact factor: 2.565

7.  Wound emergencies: the importance of assessment, documentation, and early treatment using a wound electronic medical record.

Authors:  Michael S Golinko; Sunday Clark; Robert Rennert; Anna Flattau; Andrew J M Boulton; Harold Brem
Journal:  Ostomy Wound Manage       Date:  2009-05-01       Impact factor: 2.629

8.  Suction assisted pulse lavage: randomised controlled studies comparing its efficacy with conventional dressings in healing of chronic wounds.

Authors:  Rahul Shetty; Elvino Barreto; Kingsly M Paul
Journal:  Int Wound J       Date:  2012-09-03       Impact factor: 3.315

Review 9.  Minimally Invasive Necrosectomy Techniques in Severe Acute Pancreatitis: Role of Percutaneous Necrosectomy and Video-Assisted Retroperitoneal Debridement.

Authors:  Jennifer A Logue; C Ross Carter
Journal:  Gastroenterol Res Pract       Date:  2015-10-26       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.